Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa for wet age-related macular degeneration
ISRCTN62749026Phase 3Recruiting
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Oct 2026
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of levodopa and carbidopa in exudative macular degeneration (2 arms), sponsored by Belfast Health and Social Care Trust. Started Oct 2026; status: recruiting.
02
Drugs
levodopacarbidopa
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on ISRCTN62749026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN62749026.